glp 1 binge eating disorder Experts express alarm that GLP-1 RAs may trigger or worsen disorders. But is there any role they might play in eating disorder? And how can clinicians protect patients from risk? GLP-1 Therapy: An Emerging Tool
Description
In clinical trials studying Wegovy (2.4 mg), the average weight loss was 15% and 20%, respectively, when paired with diet and exercise (compared to 2.4% and 3.1% with diet and exercise alone)

On average, resting heart rate increases by 24 beats per minute, though individual responses vary

Table 1 provides a general clinical comparison of these medication classes for the treatment of T2DM

If youre considering Qsymia or want to compare oral medications with GLP-1 injections or surgical options, our team is here to help
